Will Nutland proposes that instead of the Hollywood style ‘end of AIDS moment’ fantasy, the end of AIDS will be a process with a number of emerging endpoints. In this eye-opening talk, Will introduces a number of emerging treatments and discusses their efficacy and levels of acceptability. He surmises that the end might happen without us even noticing.

Will Nutland is a research fellow at LSHTM, having joined the School in 2008 on the DrPH programme. Will has worked in a range of community-based health and environment roles, including as Head of Health Promotion for the UK’s Terrence Higgins Trust. Fifteen years ago Will, along with other international HIV activists, started to lobby and campaign for greater research into and development of new HIV prevention technologies – including using anti-retroviral therapies to prevent HIV. This activism, lead to the wide availability of post-exposure HIV prophylaxis (PEP) and the funding of a major national education programme on PEP in England. For the last three years, Will has been researching the acceptability of pre-exposure HIV prophylaxis (PrEP) in London – a drug regime that can prevent HIV infection when exposed to HIV. Described as a ‘game changer’ in HIV prevention, PrEP activists are now seeking to ensure that this new HIV prevention tool is available on the NHS.